DermaRite Revenue and Competitors

North Bergen, NJ

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • DermaRite's estimated annual revenue is currently $23.2M per year.(i)
  • DermaRite's estimated revenue per employee is $270,000

Employee Data

  • DermaRite has 86 Employees.(i)
  • DermaRite grew their employee count by 6% last year.

DermaRite's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Sr. VP Business DevelopmentReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
SVP Clinical AffairsReveal Email/Phone
5
VP Clinical Business DevelopmentReveal Email/Phone
6
VP Human ResourcesReveal Email/Phone
7
Director Human ResourcesReveal Email/Phone
8
Director Global Procurement and SourcingReveal Email/Phone
9
Director Quality-QA/QCReveal Email/Phone
10
Director Clinical EducationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M52-4%N/AN/A
#2
$275.2M72828%N/AN/A
#3
$35.9M13310%N/AN/A
#4
$11050M288364%$48.1MN/A
#5
$18.2M7521%N/AN/A
#6
$17M703%N/AN/A
#7
$25.1M93-10%N/AN/A
#8
$24M8910%N/AN/A
#9
$17M7015%N/AN/A
#10
$9.7M45-6%N/AN/A
Add Company

What Is DermaRite?

DermaRite manufactures cost-effective skin care, wound care, and nutritional supplements for healthcare facilities, including hospitals, nursing homes, hospice, and home care. Founded in 1995, DermaRite's state of the art manufacturing and warehousing facility is in North Bergen, New Jersey. With a distribution and sales network throughout the United States, facilities can be assured of fast, reliable service and personalized attention. DermaRite customers also receive access to a wide range of clinical and educational tools, making us one of the best values in the industry. DermaRite is an FDA and OSHA approved manufacturer.

keywords:N/A

N/A

Total Funding

86

Number of Employees

$23.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M111-9%N/A
#2
$51.9M1435%N/A
#3
$7.5M16316%N/A
#4
$15M1838%N/A
#5
$65.8M1965%N/A